Brokerages Set Stericycle, Inc. (NASDAQ:SRCL) PT at $74.00

Shares of Stericycle, Inc. (NASDAQ:SRCL) have earned an average recommendation of “Hold” from the six analysts that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $74.00.

A number of research analysts have commented on SRCL shares. StockNews.com assumed coverage on shares of Stericycle in a research report on Thursday, June 13th. They issued a “hold” rating on the stock. Keefe, Bruyette & Woods upped their price objective on Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. Robert W. Baird reduced their price target on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a research report on Friday, April 26th. Stifel Nicolaus raised their price objective on shares of Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a research report on Thursday, February 29th. Finally, Truist Financial boosted their price objective on shares of Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research note on Tuesday, June 4th.

Hedge Funds Weigh In On Stericycle

A number of institutional investors have recently added to or reduced their stakes in the company. Capital Research Global Investors lifted its holdings in Stericycle by 13.4% during the 4th quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider’s stock worth $296,762,000 after buying an additional 705,586 shares during the last quarter. Robeco Institutional Asset Management B.V. acquired a new position in Stericycle in the 4th quarter worth about $156,000. Private Advisor Group LLC grew its holdings in Stericycle by 8.6% during the 4th quarter. Private Advisor Group LLC now owns 5,788 shares of the business services provider’s stock worth $287,000 after acquiring an additional 459 shares during the last quarter. Sei Investments Co. raised its position in Stericycle by 35.5% during the 4th quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider’s stock worth $52,601,000 after purchasing an additional 277,896 shares during the last quarter. Finally, Eagle Asset Management Inc. lifted its stake in shares of Stericycle by 5.5% in the fourth quarter. Eagle Asset Management Inc. now owns 303,649 shares of the business services provider’s stock worth $15,049,000 after acquiring an additional 15,790 shares during the period. Institutional investors and hedge funds own 98.82% of the company’s stock.

Stericycle Stock Performance

Shares of Stericycle stock opened at $58.63 on Friday. The firm has a market capitalization of $5.44 billion, a P/E ratio of -266.50, a PEG ratio of 3.14 and a beta of 1.08. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.55. The company has a 50 day moving average price of $50.15 and a 200 day moving average price of $50.14. Stericycle has a 52 week low of $37.78 and a 52 week high of $59.45.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The company had revenue of $664.90 million for the quarter, compared to the consensus estimate of $676.42 million. During the same quarter in the prior year, the business posted $0.49 earnings per share. Stericycle’s revenue for the quarter was down 2.8% on a year-over-year basis. Sell-side analysts expect that Stericycle will post 2.32 EPS for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.